Promoting Mental Health at Work Among Hospital Professionals (PROMIND)

January 23, 2026 updated by: Hospices Civils de Lyon

Promoting Mental Health at Work Among Hospital Professionals: Implementation and Evaluation of the Effects of an Intervention Based on Mindfulness Meditation in the Workplace - PROMIND Study

Mental health is a state of well-being in which a person can realize his/her potential, cope with the normal stresses of life, work productively and contribute to his/her community. It refers to a continuum that extends from the promotion of well-being and the prevention of mental disorders to the treatment and rehabilitation of people suffering from these disorders.

Healthcare professionals face major mental health challenges, due to the demands of their profession, which is characterized by heavy workloads and confrontation with human distress. The frequency of mental health problems among hospital staff is high, at all stages (malaise, distress, pathologies). A meta-analysis found that caregivers suffer from around 30% anxiety, 30% depression, 30% psychotrauma and 45% sleep disorders.

According to the French Labor Code, employers are responsible for the physical and mental health of their employees. The Hospices Civils de Lyon establishment project includes a section on the prevention of psycho-social risks, quality of working life and management.

Healthcare professionals, like the general population, have high expectations of non-medication treatments. These non-medication interventions aim to prevent, treat, or cure a health problem. They are non-invasive and non-pharmacological, with certain observable impacts supported by scientific evidence.

Mindfulness meditation is one of the most extensively studied non-medication interventions in mental health. Declined in different modalities, its effects focus on improving resilience with efficacy on physical and mental well-being (stress, anxiety, burnout, affect), and their physiological corollary (cardiac and respiratory rhythms), acceptance of reality in stressful situations, reduced interpersonal conflict in emergencies and, more broadly, impact on relational behaviours (anti- and pro-social), teamwork. Managers also benefit, with a strengthening of the aspiration to lead, in a vision fully at the disposal of others.

Mindfulness meditation appears to be a practice that promotes mental well-being and could contribute to fulfilment at work.

The challenge is to offer a mindfulness meditation program in a hospital department for individual and collective benefit.

The main objective is to evaluate the evolution of psychological fulfilment in the workplace of hospital healthcare professionals in a 5-month meditation program between the baseline and the end of the program, in comparison with the evolution over the same period of a control group.

The expected outcome is to show that it is possible to implement a mindfulness meditation intervention for hospital staff in care departments, whatever their status or profession, with individual and collective benefits for mental health, psycho-social risks (stress, violence, etc.) and work organization. If it proves to be effective and acceptable, this intervention could be offered more widely within the institution and beyond.

Study Overview

Study Type

Interventional

Enrollment (Actual)

108

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bron, France, 69677
        • Neurology Department, Pierre Wertheimer Hospital (Hospices Civils de Lyon)
      • Bron, France, 69677
        • Pediatric Intensive Care Unit - Continuous Monitoring, Femme Mère Enfant Hospital (Hospices Civils de Lyon)
      • Lyon, France, 69003
        • Department of Geriatrics, Edouard Herriot Hospital (Hospices Civils de Lyon)
      • Lyon, France, 69004
        • Neonatology and neonatal intensive care unit, Croix-Rousse Hospital (Hospices Civils de Lyon)
      • Lyon, France, 69437
        • Department of Anesthesia and Intensive Care, Edouard Herriot Hospital (Hospices Civils de Lyon)
      • Pierre-Bénite, France, 69495
        • Anaesthesia - Intensive Care and Perioperative Medicine Department, Lyon South Hospital (Hospices Civils de Lyon)
      • Saint-Genis-Laval, France, 69230
        • Department of Physical Medicine and Neurological Rehabilitation, Henry Gabrielle Hospital (Hospices Civils de Lyon)
      • Villeurbanne, France, 69100
        • Department of Geriatrics, Charpennes Hospital (Hospices Civils de Lyon)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being a Hospices Civils de Lyon professional working in a department participating in the project
  • Being of legal age
  • Having given written consent including voice recording for focus groups and semi-structured interviews

Exclusion Criteria:

  • Self-reported neuro-psychiatric pathology with current severe clinical instability
  • Adults under legal protection (guardianship, curators)
  • Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
  • Persons unable to understand or write in French
  • Pregnant and nursing mothers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mindfulness meditation practice group
Group informed about mindfulness meditation and experimenting with an adapted program based on mindfulness meditation (intervention group).

The information session on mindfulness meditation is an information meeting on the PROMIND study opened to all hospital professionals from the 8 participating departments, i.e. the intervention and control groups.

During this information session, it is specified that it is desirable for the non-intervention groups to maintain their usual practice (or non-practice) during the study, without starting a new practice of mindfulness meditation.

Before this meeting, the baseline questionnaires are administered. Immediately after this time, the questionnaire on representations of mindfulness meditation is administered.

After randomization, a mindfulness meditation trial session is offered to all professionals in the intervention group follow by the questionnaire on representations of mindfulness meditation administration.

Then, interdepartmental focus groups is conducted with leaders. The following mindfulness meditation program consists of 10 1-hour sessions within 15 days, in groups of up to 15 professionals, conducted at the participants' place and time of work, by a certified mindfulness meditation trainer with a recommended daily practice of 10-20 minutes with the possibility of a longer duration, and an audio guidance tool adapted to the study.

After the program, and 3 months later, questionnaires are administered for both groups.

For the intervention group, individual interviews, and inter-departmental focus groups (leaders) are carried out at the end of the intervention, and intra-departmental focus groups are conducted 3 months after the end.

Active Comparator: Group without mindfulness meditation practice
Group informed about mindfulness meditation and without experimentation of mindfulness meditation practice (control group).

The information session on mindfulness meditation is an information meeting on the PROMIND study opened to all hospital professionals from the 8 participating departments, i.e. the intervention and control groups.

During this information session, it is specified that it is desirable for the non-intervention groups to maintain their usual practice (or non-practice) during the study, without starting a new practice of mindfulness meditation.

Before this meeting, the baseline questionnaires are administered. Immediately after this time, the questionnaire on representations of mindfulness meditation is administered.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological fulfilment at work
Time Frame: Baseline: before the intervention and immediately after the intervention

Self-reported psychological fulfilment at work questionnaire for the intervention and control groups.

13-item questionnaire validated in French. Each item is scored 1-7 (1 = strong disagreement; 7 = strongly agree), yielding a total between 13 and 91 (a high score indicating a high level of psychological fulfillment at work).

Baseline: before the intervention and immediately after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological fulfilment at work
Time Frame: 3 months immediately after the end of the intervention

Self-reported psychological fulfilment at work questionnaire for the intervention and control groups.

13-item questionnaire validated in French. Each item is scored 1-7 (1 = strong disagreement; 7 = strongly agree), yielding a total between 13 and 91 (a high score indicating a high level of psychological fulfillment at work).

3 months immediately after the end of the intervention
Mindful state
Time Frame: Baseline: before the intervention, immediately after the intervention and 3 months immediately after the intervention

Intervention's impact on the mindful state measured by the Five Facet Mindfulness Questionnaire (15 items) (FFMQ-15).

Each item is scored on a 5-point Likert scale (1 = never or very rarely true; 2 = rarely true; 3 = sometimes true; 4 = often true; 5 = very often or always true).

Higher scores mean a more mindful state.

Baseline: before the intervention, immediately after the intervention and 3 months immediately after the intervention
Aggressiveness
Time Frame: Baseline: before the intervention, immediately after the intervention and 3 months immediately after the intervention

Intervention's impact on aggressiveness measured by the 12-item Aggression Questionnaire (AQ12).

Each item is scored from 1 to 6 (1 = not me at all; 6 = quite me). Higher scores mean a higher level of aggressiveness.

Baseline: before the intervention, immediately after the intervention and 3 months immediately after the intervention
Impulsivity, experience of being disturbed by conflict, and psychological safety.
Time Frame: Baseline: before the intervention, immediately after the intervention and 3 months immediately after the intervention

Intervention's impact on impulsivity, experience of being disturbed by conflict, patient support, and psychological safety measured by a visual analog scale (VAS).

The VAS ranges from "not at all" (0) to "completely" (10). Higher scores mean a greater impulsivity, a greater experience of being disturbed by conflict and a greater psychological safety.

Baseline: before the intervention, immediately after the intervention and 3 months immediately after the intervention
Occupational stress
Time Frame: Baseline: before the intervention, immediately after the intervention and 3 months immediately after the intervention

Intervention's impact on occupational stress measured by the Job content questionnaire (26 items) Each item is scored from 1 to 4 on a 4-point Likert scale (1 = strongly disagree; 2 = disagree; 3 = agree; 4 = strongly agree).

The higher the scores, the higher the levels of occupational stress.

Baseline: before the intervention, immediately after the intervention and 3 months immediately after the intervention
Collective activity
Time Frame: Baseline: before the intervention, immediately after the intervention and 3 months immediately after the intervention

Intervention's impact on collective activity ameasured with 4 items by self-assessment using a visual analog scale (VAS).

Each item is scored from 0 to 10 (0 = strongly disagree; 10 = strongly agree). A higher score indicating greater collective activity.

Baseline: before the intervention, immediately after the intervention and 3 months immediately after the intervention
Organizational leeway
Time Frame: Baseline: before the intervention, immediately after the intervention and 3 months immediately after the intervention

Intervention's impact on organizational leeway measured by a a visual analog scale (VAS).

Item 1 is scored with a 5-point VAS (always; most of the time; sometimes; rarely; never). Item 2 is score with a 4-point VAS (never; sometimes; often; always). Items 3 and 4 are scored from 0 to 5 (0 = strongly disagree; 5 = strongly agree).

A high frequency on item 1, a low frequency on item 2, a low score on item 3 and a high score on item 4 each indicate higher organizational leeway.

Baseline: before the intervention, immediately after the intervention and 3 months immediately after the intervention
Evolution of participants' representation of mindfulness meditation
Time Frame: Before and after the information session on mindfulness meditation, immediately after the first experimental session, immediately after the program and 3 months after the program

The evolution of participants' representation of mindfulness meditation is measured by Devilly and Borkovec's adapted credibility and expectations questionnaire (6 items).

Items 1 (I), 2 (I), 3 (I) and 1 (II) are scored from 1 to 9 (1 = not at all consistent /helpful /confident; 9 = very consistent /helpful /confident) and items 4 (I) and 2 (II) are scored from 0% to 100%. An expectancy score is provided by items 4 (I), 1 (II) and 2 (II). A credibility score is provided by items 1 (I), 2 (I), and 3 (I). Higher scores indicate higher levels of expectancy and credibility.

Before and after the information session on mindfulness meditation, immediately after the first experimental session, immediately after the program and 3 months after the program
The representation of mindfulness meditation among professionals
Time Frame: Before the program, up to 12 months , 1 and 3 months after the end of the intervention
Description of the representation of mindfulness meditation measured from verbatim from focus groups.
Before the program, up to 12 months , 1 and 3 months after the end of the intervention
The representation of mindfulness meditation among professionals
Time Frame: 1 and 3 months after the end of the intervention
Description of the representation of mindfulness meditation measured from semi-structured interviews.
1 and 3 months after the end of the intervention
The representation of mindfulness meditation among professionals
Time Frame: up to 12 months
Description of the representation of mindfulness meditation measured from verbatim from observation reports.
up to 12 months
Fidelity and adherence to the mindfulness meditation intervention
Time Frame: At study completion, an average of 15 months
Assessing the number of sessions attended, participants and practices in daily life.
At study completion, an average of 15 months
Fidelity and adherence to the mindfulness meditation intervention
Time Frame: At study completion, an average of 15 months
Assessing the duration of the sessions
At study completion, an average of 15 months
Barriers and facilitators to the implementation
Time Frame: At study completion, an average of 15 months
Assessing barriers and facilitators to the implementation through verbatim from focus groups.
At study completion, an average of 15 months
Barriers and facilitators to the implementation
Time Frame: At study completion, an average of 15 months
Assessing barriers and facilitators to the implementation through verbatim from semi-structured interviews.
At study completion, an average of 15 months
Mechanisms of the intervention effects
Time Frame: At study completion, an average of 15 months

Qualitative exploration and description of intervention effects and the mechanisms by which they are produced.

The objective and methods are open-ended, with no preconceived ideas about the effects produced by the intervention, their mechanisms, and the way in which these mechanisms may be activated (or not) depending on the implementation context. It is based on a triangulation of three complementary methods: 1- non-participant observation.

At study completion, an average of 15 months
Mechanisms of the intervention effects
Time Frame: At study completion, an average of 15 months

Qualitative exploration and description of intervention effects and the mechanisms by which they are produced.

It is based on a triangulation of three complementary methods: 2- focus groups.

At study completion, an average of 15 months
Mechanisms of the intervention effects
Time Frame: At study completion, an average of 15 months

Qualitative exploration and description of intervention effects and the mechanisms by which they are produced.

It is based on a triangulation of three complementary methods: 3- semi-structured individual interviews.

At study completion, an average of 15 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ludivine NOHALES, Hospices Civils de Lyon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2024

Primary Completion (Actual)

November 30, 2024

Study Completion (Actual)

June 30, 2025

Study Registration Dates

First Submitted

February 21, 2024

First Submitted That Met QC Criteria

March 21, 2024

First Posted (Actual)

March 26, 2024

Study Record Updates

Last Update Posted (Actual)

January 26, 2026

Last Update Submitted That Met QC Criteria

January 23, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health Issue

Clinical Trials on Information session on mindfulness meditation and questionnaires

Subscribe